European Association of Urology Guidelines Panel on Renal Cell Carcinoma Update on the New World Health Organization Classification of Kidney Tumours 2022: The Urologist's Point of View
Jazyk angličtina Země Švýcarsko Médium print-electronic
Typ dokumentu úvodníky
PubMed
36435661
DOI
10.1016/j.eururo.2022.11.001
PII: S0302-2838(22)02788-9
Knihovny.cz E-zdroje
- MeSH
- karcinom z renálních buněk * patologie MeSH
- lidé MeSH
- nádory ledvin * patologie MeSH
- Světová zdravotnická organizace MeSH
- urologie * MeSH
- urologové MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- úvodníky MeSH
The fifth edition of the World Health Organization (WHO) classification of urogenital tumours published in 2022 will be implemented in the European Association of Urology guidelines on renal cell carcinoma for 2023. Here we provide an update summarising changes in the new WHO classification of renal tumours from a clinician perspective.
Department of Cancer Medicine Gustave Roussy Université Paris Saclay Villejuif France
Department of Surgical and Perioperative Sciences Urology and Andrology Umeå University Umeå Sweden
Department of Translational Medicine Division of Urological Cancers Lund University Malmö Sweden
Department of Urology Cabueñes University Hospital Gijón Spain
Department of Urology Chaim Sheba Medical Center Tel Hashomer Ramat Gan Israel
Department of Urology Charité Universitätsmedizin Berlin Berlin Germany
Department of Urology Coimbra University Hospital Coimbra Portugal
Department of Urology Homerton University Hospital London UK
Department of Urology Sunderby Sjukhus Umeå University Luleå Sweden
Department of Urology University of Eastern Piedmont Maggiore della Carità Hospital Novara Italy
International Kidney Cancer Coalition Duivendrecht The Netherlands
The Royal Free NHS Trust and Barts Cancer Institute Queen Mary University of London London UK
Citace poskytuje Crossref.org
Non-coding transcriptome profiles in clear-cell renal cell carcinoma